CRYO CELL INTERNATIONAL INC (CCEL) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$4.35

From 52W high+0.00%

Volume7895.00

Market cap$37.49M

P/E (TTM)—

P/S (TTM)1.2x

Div yield—

Key dataOct 19, 2026

Open

$4.35

From 52W high

+0.00%

Volume

7895.00

Market cap

$37.49M

ValuationView details →

P/E (Fwd)

66.4x

EV/EBITDA

28.3x

P/E (TTM)

—

RSI (14)

59.3

MomentumView details →

1D Return

+5.20%

YTD Return

+37.50%

SummaryUpdated Aug 1, 2026

Cryo-Cell International, Inc. (NASDAQ:CCEL) is a pioneering biotechnology company founded in 1989 and headquartered in Oldsmar, Florida. The company went public in 1994 and has established itself as a leader in the cellular processing and cryogenic storage industry, specifically focusing on umbilical cord blood and tissue preservation. With approximately 500,000 cord blood and cord tissue stem cell units stored worldwide, Cryo-Cell has built one of the largest private cord blood banks globally, serving families who seek to preserve their newborn's stem cells for potential future medical treatments.

Ask drillr about CRYO CELL INTERNATIONAL INC →

ValuationView details →

P/E (Fwd)

66.4x

P/E (TTM)

—

EV/EBITDA

28.3x

EV/Sales

1.1x

P/S (TTM)

1.2x

P/B (TTM)

−2.3x

ProfitabilityView details →

Gross Margin

77.95%

Net Margin

−9.05%

EBITDA Margin

3.84%

ROE (TTM)

17.19%

ROA (TTM)

−4.52%

Asset Turnover

0.51x

GrowthView details →

Revenue YoY

−1.96%

EPS YoY

—

FCF YoY

−23.11%

Revenue CAGR 3Y

+1.33%

EPS CAGR 3Y

—

EBITDA YoY

−76.83%

MomentumView details →

1D Return

+5.20%

YTD Return

+37.50%

1Y Return

+4.65%

RSI (14)

59.3

vs 50D SMA

+14.52%

vs 200D SMA

+30.63%

Capital & dividendView details →

Debt/Equity

−0.04x

Current Ratio

0.86x

Quick Ratio

0.82x

Div Yield

—

Div Rate

—

Div Growth 1Y

+60.00%

EarningsView details →

EPS (Actual)

$0.16

EPS Surprise

433.33%

Beats (12Q)

10/12

Next Q EPS Est

$0.05

Avg Surprise (4Q)

316.67%

Rev Surprise

4.92%

Financials snapshotView financials →

Revenue (TTM)

31.13M

Net Income (TTM)

−2.82M

Op. CF (TTM)

4.92M

Next earningsFeb 26, 2027 →

Latest newsMore news →

Cryo-Cell International reported fiscal third-quarter 2026 revenue of $7.82 million and net income of $1.27 million.10d ago

Cryo-Cell International, Inc. reported its financial results for the fiscal second quarter ended May 31, 2026.96d ago

Similar companies

SoftMedx Healthcare Limited00648.HK biote Corp.BTMD The Oncology Institute, Inc.TOIIW MediNet Group Limited08161.HK DocGo Inc.DCGO Raily Aesthetic Medicine International Holdings Limited02135.HK Find similar companies →

Latest newsMore news →

Cryo-Cell International reported fiscal third-quarter 2026 revenue of $7.82 million and net income of $1.27 million.10d ago Cryo-Cell International, Inc. reported its financial results for the fiscal second quarter ended May 31, 2026.96d ago